Everything below concerns heptapeptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-11-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. The first four residues correspond to the ACTH(4-10) fragment, while the terminal Pro-Gly-Pro extension was added to improve metabolic stability. Its molecular formula is C37H51N9O10S and its monoisotopic mass is approximately 813.9 Da. The compound is classified as a peptide research chemical and as a registered pharmaceutical product in Russia, but it does not hold marketing approval in the European Union or the United States. Naming conventions vary across supplier catalogs.
Development of the compound took place in the Soviet Union during the 1980s, largely through peptide research groups affiliated with the Shemyakin-Ovchinnikov Institute and Moscow State University. Investigators screened fragments of adrenocorticotropic hormone for activity on the central nervous system while attempting to separate cognitive effects from hormonal ones. The shortened sequence was selected because it retained behavioral activity in animal models without stimulating corticosteroid release. Early publications described the molecule as an ACTH(4-10) analog.
Published research on this peptide originates mainly from Russian laboratories, and the wider international literature is comparatively thin. Studies have used rodent models of stroke, hypoxia, and memory tasks, with a smaller number of human trials reported. Reported outcomes include changes in attention and memory measures, along with effects on neurotrophic factor expression in some experiments. Small sample sizes, inconsistent dosing protocols, and limited independent replication are widely noted limitations, so the strength of the clinical evidence remains an open question.
The C-terminal Pro-Gly-Pro extension is not incidental. Proline-rich tails are known to resist several common peptidases, and the published literature attributes the longer half-life of Semax, relative to unmodified ACTH fragments, to this feature. The modification also removes the melanocyte-stimulating and corticosteroidogenic activity that characterizes longer ACTH-derived sequences. Because the molecule is small and hydrophilic, it is typically formulated as an aqueous solution for intranasal or parenteral delivery. Acetylation or amidation at the termini appears in closely related research peptides and shifts the mass by a fixed increment.
Reported pharmacological work centers on neurotrophic signaling, including changes in BDNF and NGF expression in hippocampal tissue in animal models. Human data come largely from studies conducted in Russia, and how well those results generalize to other populations remains an open question. Regulatory status differs sharply by jurisdiction: Semax is a registered prescription medicine in Russia, while it holds no approved marketing status in the United States or the European Union. Outside such jurisdictions it is generally handled as a research chemical, which affects both documentation and quality expectations.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It was developed as a fragment analog of adrenocorticotropic hormone, modeled specifically on the ACTH(4-10) region. The first four residues reproduce that fragment, while a Pro-Gly-Pro tripeptide is appended at the C-terminus. Work on the compound originated in Russia, where it entered clinical use as an intranasal preparation. Its sequence places it among short regulatory peptides studied for effects on the central nervous system rather than on the adrenal axis.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C37H51N9O10S | Seven-residue peptide |
| Molecular mass | 813.9 Da | Monoisotopic value |
| Appearance | White to off-white powder | Lyophilized form |
| Solubility | Freely soluble in water | Also soluble in saline and polar solvents |
| Storage (dry) | -20 °C or lower | Desiccated, protected from light |
Pharmacological accounts link semax to melanocortin signalling and to modulation of neurotrophic factor expression, particularly brain-derived neurotrophic factor and nerve growth factor. Much of this evidence comes from rodent studies using intranasal delivery, a route chosen because it allows peptides to reach the central nervous system with limited systemic exposure. Whether the same mechanisms operate in humans at comparable magnitude remains an open question. The precise receptor or receptors responsible for the reported behavioural and neuroprotective effects have not been conclusively identified.
Clinical reports describe use in ischaemic stroke, transient ischaemic attack, optic nerve conditions, and cognitive complaints, but most of these studies are small and were conducted in a single region. Systematic reviews have generally described the evidence base as limited in size and variable in methodological quality. Randomised controlled data suitable for international regulatory assessment are scarce. As a result, major treatment guidelines outside Russia do not include the peptide, and interest in it remains largely research-driven rather than routine clinical.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.
Development took place during the 1980s at institutes of the Russian Academy of Sciences, where peptide fragments of ACTH were screened for cognitive and neuroprotective effects. The compound received regulatory approval in Russia as a nasal preparation, marketed for conditions such as ischemic stroke, transient ischemic attacks, and optic nerve disorders. Registration in other countries has not followed. Most published clinical reports originate from a small number of Russian research groups, and independent replication outside that setting remains limited. The regulatory status therefore differs sharply between Russia and the rest of the world.
Laboratory work points toward modulation of neurotrophic signaling, particularly expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal tissue. Studies also describe effects on monoamine turnover, inflammatory mediators, and oxidative markers. These observations come mainly from animal models and cultured cells, so the causal chain in humans is not firmly established. Whether the reported molecular changes translate into measurable clinical benefit is an open question. Reviews generally present the mechanism as plausible rather than demonstrated.
In November 2023, the two debated, with Fox News's Sean Hannity as moderator. In July 2024, Newsom launched a podcast, Politickin', co-hosted by Marshawn Lynch and Doug Hendrickson. After Biden's sudden withdrawal from the presidential race that month, Newsom said he would not seek the Democratic nomination, and endorsed Vice President Kamala Harris for president. After Donald Trump won the 2024 election, Newsom called for California lawmakers to convene later in 2024 to safeguard California's policies from the second Trump administration. In December 2024, Newsom criticized Biden for pardoning his son Hunter, saying, "I'm disappointed and can't support the decision." Since the 2024 U.S. presidential election, Newsom has repeatedly declined to identify himself with either the progressive or moderate faction of the Democratic Party, calling such labels "reductive" and calling himself a "hard-headed pragmatist". He said he wants the Democratic Party to be an "inclusive" big tent, spanning the ideological spectrum "from Manchin to Mamdani". In August 2025, Newsom began communicating on social media platforms in a style intended to mock Trump's style of online communication. In June 2026, Newsom said the United States Department of Justice was prosecuting him and his wife at Trump's direction.
As the mainland economy liberalised, Hong Kong's shipping industry faced intense competition from other Chinese ports. Half of China's trade goods were routed through Hong Kong in 1997, dropping to about 13% by 2015. The territory's minimal taxation, common law system, and civil service attract overseas corporations wishing to establish a presence in Asia. The city has the second-highest number of corporate headquarters in the Asia-Pacific region. Hong Kong is a gateway for foreign direct investment in China, giving investors open access to mainland Chinese markets through direct links with the Shanghai and Shenzhen stock exchanges. The territory was the first market outside mainland China for renminbi-denominated bonds, and is one of the largest hubs for offshore renminbi trading. In November 2020, Hong Kong's Financial Services and the Treasury Bureau proposed a new law that will restrict cryptocurrency trading to professional investors only, leaving amateur traders (93% of Hong Kong's trading population) out of the market. The Hong Kong dollar, the local currency, is the eighth-most traded currency in the world. Due to extremely compact house sizes and the extremely high housing density, the city has the most expensive housing market in the world. The government has had a passive role in the economy. Colonial governments had little industrial policy and implemented almost no trade controls.
=== United States === Cannabis tea is scheduled at the federal level in the United States by nature of being a derivative of Cannabis sativa, and it is therefore illegal to possess, buy, and sell. Due to variances in statewide laws, and the reluctance of the federal government to overrule the states, however, the federal legislation has little impact on nationwide use, and is "generally applied only against persons who possess, cultivate, or distribute large quantities of cannabis". As such, regulation of recreational and/or medicinal growth and use on an individual level is not the responsibility of the federal government.
== Society == In March 2013, there was media coverage of a British 7-year-old boy named Owen, with chronically tense muscles due to SJS, and his three-legged pet dog. They became first-place winners of the 2013 Crufts Kennel Club's annual Friends for Life competition, which "celebrates dogs that have truly earned the title of man’s best friend through bravery, support or companionship". The dog was also awarded The Braveheart Honour in the ceremony of The British Animal Honours in April 2013 (Haatchi the dog). The two are featured in the book Haatchi & Little B (2014, ISBN 125-006-936-X) by Wendy Holden and on Haatchi's Facebook page. In 2016, 9-year-old Owen was featured in a TLC documentary series, Two in a Million, in which he met and formed a friendship with Giovanni, a 7-year-old American boy with SJS.
Sources: en.wikipedia.org
== Treatment == Systemic steroids are considered the first line treatment for organizing pneumonia, with patient's often having clinical improvement within 72 hours of steroid initiation and most patients achieving recovery. A prolonged treatment course is indicated, with patients usually requiring at least 4–6 months of treatment. Patients who are treated with larger doses of steroids require prophylaxis against Pneumocystis jirovecii. Relapses may occur and are more likely to occur in severe disease or when steroids are tapered too soon or too quickly. Alternative or adjunct treatment options include macrolide antibiotics (due to anti-inflammatory properties), azathioprine and cyclophosphamide.
We thus come to the remarkable conclusion that, beyond doubt, Van Leeuwenhoek in his experiment with the fully closed tube had cultivated and seen genuine anaerobic bacteria, which would happen again only after 200 years, namely about 1862 by Pasteur. That Leeuwenhoek, one hundred years before the discovery of oxygen and the composition of air, was not aware of the meaning of his observations is understandable. But the fact that in the closed tube he observed an increased gas pressure caused by fermentative bacteria and, in addition, saw the bacteria, prove, in any case, that he not only was a good observer but also was able to design an experiment from which a conclusion could be drawn.
== Selected publications == Gillman, K. W.; et al. (2010). "Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor". ACS Medicinal Chemistry Letters. 1 (3): 120–124. doi:10.1021/ml1000239. PMC 4007960. PMID 24900185. Luo, G.; et al. (2012). "Discovery of (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): an oral calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraine". Journal of Medicinal Chemistry. 55 (23): 10644–10651. doi:10.1021/jm3013147. PMID 23153230.
== Popular uses == Flector (diclofenac epolamine) patch is an NSAID topical patch for the treatment of acute pain due to minor strains, sprains, and contusions. It is also being used in the treatment of pain and inflammation for chronic conditions benefiting from NSAIDs, including fibromyalgia and arthritis. Lidocaine patches, marketed as Lidoderm, relieve the peripheral pain of shingles (herpes zoster). It became commonly used off-label, for pain from acute injuries and chronic pain, although limited by its requirement to be removed for 12 hours, after 12 hours of use. Some experimental studies investigate the use of ceramic dermal patches for local antibiotic delivery to contaminated commercial skin graft patches, and antibiotic dermal patches to deliver local antibiotic to the gum after dental surgery.
29 June – A spokesman for Reform UK confirms the party has dropped three candidates for making offensive comments. They are Edward Oakenfull (Derbyshire Dales), Robert Lomas (Barnsley North), and Leslie Lilley (Southend East and Rochford), but the candidates will still appear on the ballot paper as Reform candidates because it is too late for them to be removed. East Lothian Council becomes the third local authority to establish an emergency facility for people who have not received their postal votes. The Northern Ireland Conservatives launch their election manifesto with the help of Chris Heaton-Harris, the Secretary of State for Northern Ireland. Policies include upholding the Good Friday Agreement and continuing to invest in Northern Ireland. The Conservatives are fielding five candidates in Northern Ireland. 30 June – The Sunday Times endorses the Labour Party for the first time since the 2001 general election. Liam Booth-Isherwood, the Reform UK candidate for Erewash, disowns the party, citing a "significant moral issue" following recent reports of "widespread racism and sexism", and gives his backing to the Conservatives.
Sources: en.wikipedia.org
A 15-hydroxyicosatetraenoate dehydrogenase metabolizes 15-hydroxyicosatetraenoic acid (i.e. 15(S)-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid or 15-HETE) to its 15-keto analog, 15-oxo-ETE, using NAD+ and NADH rather than NADP+ and NADPH as its co-factors. 15-Oxo-ETE appears to have a somewhat different spectrum of activities than its precursor, 15-HETE (see 15-Hydroxyicosatetraenoic acid
Lawrencium is a synthetic chemical element; it has symbol Lr (formerly Lw) and atomic number 103. It is named after Ernest Lawrence, inventor of the cyclotron, a device used to discover many artificial radioactive elements. A radioactive metal, lawrencium is the eleventh transuranium element, the third transfermium, and the last member of the actinide series. Like all elements with atomic numbers over 100, lawrencium can only be produced in particle accelerators by bombarding lighter elements with charged particles. Fourteen isotopes of lawrencium are known; the most stable is 266Lr with half-life 11 hours, but the shorter-lived 260Lr (half-life 2.7 minutes) is most commonly used in chemistry because it can be produced on a larger scale. Chemistry experiments confirm that lawrencium behaves as a heavier homolog to lutetium in the periodic table, and is trivalent. It could thus also be classified as the first of the 7th-period transition metals. Its electron configuration is anomalous for its position in the periodic table, having an s2p configuration instead of the s2d configuration of its homolog lutetium. However, this does not appear to affect lawrencium's chemistry. In the 1950s, 1960s, and 1970s, many claims of synthesis of element 103 of varying quality were made by laboratories in the Soviet Union and the United States. The priority of the discovery and therefore the name of the element was disputed between Soviet and American scientists.
== History == It was developed by Boehringer Ingelheim, patented in 2005, and is co-marketed by Eli Lilly and Company. For cardiovascular death, the FDA based its decision on a postmarketing study it required when it approved empagliflozin in 2014, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Empagliflozin was studied in a postmarket clinical trial of more than 7,000 participants with type 2 diabetes and cardiovascular disease. In the trial, empagliflozin was shown to reduce the risk of cardiovascular death compared to a placebo when added to standard of care therapies for diabetes and atherosclerotic cardiovascular disease. For heart failure, the safety and effectiveness of empagliflozin were evaluated by the FDA as an adjunct to standard of care therapy in a randomized, double-blind, international trial comparing 2,997 participants who received empagliflozin, 10 mg, once daily to 2,991 participants who received the placebo. The main efficacy measurement was the time to death from cardiovascular causes or need to be hospitalized for heart failure. Of the individuals who received empagliflozin for an average of about two years, 14% died from cardiovascular causes or were hospitalized for heart failure, compared to 17% of the participants who received the placebo. This benefit was mostly attributable to fewer participants being hospitalized for heart failure. The FDA granted the application for empagliflozin priority review, and approved the additional indication of heart failure in 2022.
==== September 2008 ==== On 1 September 2008, journalist of Nezavisimaya Gazeta wrote: "As early as 6 August I saw our army in full combat readiness near the Georgian border." On 2 September 2008, it was reported that several soldiers' mothers had sent letter to Commissioner for Human Rights in Perm Krai. One mother wrote that on 3 August his son said his unit might be deployed to the border. Another mother said that his son told her on 9 August that his unit was sent to South Ossetia on the evening of 7 August. On 11 September 2008, Yulia Latynina wrote that journalists who were sent in advance to cover the war reported on 6 August 2008 that they have seen "58th Army in full combat readiness on the other [Georgian] side of the Roki tunnel". On 15 September 2008, Novaya Gazeta reported that the South Ossetian soldier had told journalist that after the end of "Kavkaz 2008" exercises 80 tanks remained in South Ossetia. Journalist had also spoken with several Russian soldiers during her visit and they said they had been based in South Ossetia for a month, since 6 August 2008. The journalist noted that the Russian forces did not officially participate in the battle for Tskhinvali on 8 August, apparently waiting until the Georgian troops take the city, so later they could destroy both Tskhinvali and the Georgians. The construction of the road from Tskhinvali to Akhalgori had started 2 years ago.
Sources: en.wikipedia.org
It is a synthetic peptide of seven amino acids. Its backbone corresponds to a fragment of adrenocorticotropic hormone extended at the carboxyl end. The material is distributed as a lyophilized solid for laboratory use.
The extension was introduced to slow enzymatic breakdown of the peptide in biological systems. Natural ACTH fragments are degraded rapidly by peptidases. Adding the tripeptide was intended to extend the window during which the molecule remains intact.
Most published work consists of animal experiments conducted in a small number of laboratories. Human data are limited in number and size. Whether the observed effects translate into reliable clinical benefit is still unresolved.
The sequence is Met-Glu-His-Phe-Pro-Gly-Pro, a seven-residue peptide. The first four residues correspond to the ACTH(4-10) fragment, and Pro-Gly-Pro is added at the C-terminus. N-acetylated versions also appear in the literature and differ in mass.